Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
Follicular thyroid cancer is the second most common differentiated thyroid cancer
histological type and has been overshadowed by its more common counterpart—papillary …
histological type and has been overshadowed by its more common counterpart—papillary …
Follow-up of differentiated thyroid cancer–what should (and what should not) be done
L Lamartina, G Grani, C Durante, I Borget… - Nature Reviews …, 2018 - nature.com
The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …
more personalized protocols that range from active surveillance to total thyroidectomy …
[HTML][HTML] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S Filetti, C Durante, D Hartl, S Leboulleux, LD Locati… - Annals of …, 2019 - Elsevier
This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …
Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: toward the “right” TIRADS
G Grani, L Lamartina, V Ascoli, D Bosco… - The Journal of …, 2019 - academic.oup.com
Context The prevalence of thyroid nodules in the general population is increasingly high,
and at least half of those biopsied prove to be benign. Sonographic risk-stratification …
and at least half of those biopsied prove to be benign. Sonographic risk-stratification …
[HTML][HTML] Interobserver agreement of various thyroid imaging reporting and data systems
G Grani, L Lamartina, V Cantisani… - Endocrine …, 2018 - ec.bioscientifica.com
Ultrasonography is the best available tool for the initial work-up of thyroid nodules.
Substantial interobserver variability has been documented in the recognition and reporting …
Substantial interobserver variability has been documented in the recognition and reporting …
[HTML][HTML] Personalized management of differentiated thyroid cancer in real life–practical guidance from a multidisciplinary panel of experts
A Campennì, D Barbaro, M Guzzo, F Capoccetti… - Endocrine, 2020 - Springer
Purpose The standard of care for differentiated thyroid carcinoma (DTC) includes surgery,
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …
Deep learning on ultrasound images of thyroid nodules
Due to safety, easy accessibility, noninvasively and cost-effectiveness of ultrasound
imaging, this technology becomes one of the main contributors for analyzing thyroid …
imaging, this technology becomes one of the main contributors for analyzing thyroid …
Contemporary debates in adult papillary thyroid cancer management
DSA McLeod, L Zhang, C Durante… - Endocrine …, 2019 - academic.oup.com
An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …
health care systems around the world. Numerous questions about optimal management …
[HTML][HTML] Recent advances in managing differentiated thyroid cancer
The main clinical challenge in the management of thyroid cancer is to avoid over-treatment
and over-diagnosis in patients with lower-risk disease while promptly identifying those …
and over-diagnosis in patients with lower-risk disease while promptly identifying those …
Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American …
C Cox, M Bosley, LB Southerland, S Ahmadi, J Perkins… - Surgery, 2018 - Elsevier
Background The American Thyroid Association recommended thyroid lobectomy as an
alternative for low-risk differentiated thyroid cancer. One hypothetical benefit includes …
alternative for low-risk differentiated thyroid cancer. One hypothetical benefit includes …